Faculty of Biology, Medicine and Health

The University of Manchester

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities

  Investigating inequalities in the safety of artificial intelligence triage in general practice

  Dr Benjamin Brown, Dr Sudeh Cheraghi-Sohi, Prof E Kontopantelis  No more applications being accepted  Funded PhD Project (UK Students Only)

About the Project

Background

GP practices in England provide over 30 million appointments per month. Some are for urgent medical conditions that require urgent treatment where delays in care can lead to patient harm. Since 2020, almost all GP practices in England have provided online consultations where patients can request help over the internet. Online consultations are received by GP practices unprioritised which can worsen care delays. A potential solution is for the online consultation system to triage patients using artificial intelligence (AI). AI Triage is already used in NHS GP practices despite there being little evidence for its safety or whether this varies based on patient characteristics.

Aim

To evaluate the safety of AI Triage in GP practices and whether it varies according to patient clinical and sociodemographic characteristics including age, sex, socioeconomic deprivation, and ethnicity.

Methods

The candidate will evaluate exemplar online consultation systems with AI Triage (e.g. Patchs, www.patchs.ai). They will join a wider team funded by NIHR (NIHR153121). The project will comprise three workstreams and will use Systems Thinking models (e.g. SEIPS) as an overarching theoretical framework:

WS1 – Literature review: Systematic review of the research literature on AI Triage with a focus on implications for patient safety outcomes and safety inequalities. The outputs will be used to select aspects of patient safety to investigate in workstreams 2 and 3.

WS2 – Qualitative: In-depth ethnographic case studies at purposively selected GP practices supplemented by interviews with patients and GP practice staff. The objective will be to explore how and why AI Triage may affect safety in different patient groups, and how negative impacts could be minimised or eliminated.

WS3 – Quantitative: Controlled interrupted time series analysis of patient safety outcomes, and analysis of counterfactual AI Triage predictions. Subgroup analyses and statistical modelling will assess for the influence of patient clinical and sociodemographic characteristics.

Workstreams 2 and 3 will be conducted concurrently to integrate their findings. A workshop will combine findings from all three workstreams.

Collaborative partners

The candidate will develop links with industry by working with the Patchs team, national NHS policymakers by working with NHS Digital, and Systems Thinking experts aligned with the PSRC.

Impact

Findings will be used to inform NHS Digital policy on how to design and evaluate AI Triage in practice, and to create ‘how-to’ guides for GP practices and patients on how best to use AI Triage.

Training and support

The PhD candidate will be supervised by experts in online consultations, qualitative and quantitative methodologies.

Entry Requirements

Candidates are expected to hold (or be about to obtain) a minimum upper second class undergraduate honours degree (or equivalent) in a related area / subject.

For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (https://www.bmh.manchester.ac.uk/study/research/apply/).  Interested candidates must first make contact with the Primary Supervisor prior to submitting a formal application, to discuss their interest and suitability for the project. On the online application form select PhD Medicine.

Computer Science (8) Medicine (26) Nursing & Health (27)

Funding Notes

Funding for this project is through Joint SPCR-GM PSRC PhD Studentship for a duration of 3 years and covers UK tuition fees, running costs and annual stipend. Due to funding restrictions the studentship is only open to UK nationals.


Where will I study?

Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.

Faculty of Biology, Medicine and Health

Tackle real world challenges, make a difference, and elevate your career with postgraduate research in the Faculty of Biology, Medicine and Health at Manchester. From biochemistry to neuroscience, cancer sciences to medicine, audiology to mental health and everything in between, we offer a wide range of postgraduate research projects, programmes and funding which will allow you to immerse yourself in an area of research you’re passionate about.

Why study at Faculty of Biology, Medicine and Health?

Ranked the best place to live in the UK (The Economist Global Liveability Index, 2022), Manchester boasts world-class culture, iconic sports, a thriving music and food scene, and much more. It's not just a place to research, it's a place to call home.

Experience PhD life as part of a diverse postgraduate research community of more than 1,000 postgraduate researchers at the 29th most international university in the world (Times Higher Education, 2023).

With 93% of research activity at the University rated as 'world-leading' or 'internationally excellent' (Research Excellence Framework, 2021), you'll get the chance to have an impact on global health and science challenges.

1000+

postgraduate students

90

PhDs

6

ranked in UK - QS (2025)

Manchester  United Kingdom

main campus

About Faculty of Biology, Medicine and Health

At Manchester, postgraduate researchers are at the heart of our mission to tackle pressing global challenges in biological, medical and healthcare sciences - and you could be too.

By choosing Manchester for your postgraduate research, you’ll be joining a university with an exceptional research reputation, where 93% of research is world-leading or internationally excellent (REF, 2021) and where your work will have real-world impact.

You’ll research in world-class facilities alongside leading experts at the forefront of innovation, collaborating across disciplines to pioneer new treatments, advance scientific knowledge, and improve healthcare globally.

Supported by our dedicated Doctoral Academy and strong industry links, you'll experience PhD life in a vibrant, welcoming and diverse postgraduate research community.

And you’ll leave with the specialist knowledge, research experience and transferable skills that will shape your future in academia, research or industry.


Main campus

The University of Manchester

Manchester

North West

United Kingdom

PhD saved sucessfully

(MB-PhD) Gene regulatory networks driving metastatic progression in oesophageal adenocarcinoma

Oesophageal adenocarcinoma (OAC) incidence is increasing and yet survival rates remain very poor. There are limited treatment options, especially for metastatic disease, which is especially problematic as patients usually present with late stage disease. Read more
More details

(MB-PhD) MYST Histone Acetyltransferases as Therapeutic Targets in Acute Myeloid Leukaemia

Cytotoxic chemotherapy has been the standard of care for treatment of acute myeloid leukaemia (AML) for the last 50 years. Unfortunately, more often than not, it fails to cure patients, and the 5 years survival rate for all-comers with AML is only around 20%. Read more
More details

(MB-PhD)Immunomodulation in multiple myeloma

Multiple myeloma is a devastating B-cell malignancy for which there is no cure. The development of immunomodulatory drugs (IMiDs) has proved transformative to multiple myeloma care, however, their remain unanswered questions related to the mechanism of action of this important drug class. Read more
More details

A novel role in mitochondrial homeostasis for the anti-ageing factor RBBP5

The mitochondrion has evolved from the endosymbiotic interaction of an alpha-proteobacterium and an archaeon. One major event during this evolution was the transferring of genes from the symbiont to the host. Read more
More details